References
Bach, J.F.: New trends in non-antigen-specific immunosuppression. Trans. Proc.11, 1, 851 to 854 (1974)
Borel, J.F., Feurer, C., Gubler, H.U., Stahelin, H.: Biological effects of Cyclosporin A: A new antilymphocytic agent. Agents Actions6/4, 468–475 (1976)
Borel, J.F.: Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology31, 631–641 (1976)
Burckhardt, J.J., Guggenheim, B.: Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function. Immunology36, 753–757 (1979)
Calne, R.Y., White, D.J.G.: Cyclosporin A — a powerful immunosuppressant in dogs with renal allografts. IRCS Med. Sci.5, 595 (1977)
Calne, R.Y., White, D.J.G., Rolles, K., Smith, D.P., Herbertson, B.M.: Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. LancetI (8075), 1183–1185 (1978)
Calne, R.Y., White, D.J.G., Thiru, S., Evans, D.B., McMaster, P., Dunn, D.C., Craddock, G.N., Pentlow, B.D., Rolles, K.: Cyclosporin A in patients receiving renal allografts from cadaver donors. LancetII, 1327–1331 (1978)
Calne, R.Y., White, D.J.G., Pentlow, B.D., Rolles, K., Syrakos, T., Olitawa, T., Smith, D.P., McMaster, P., Evans, D.B., Herbertson, B.M., Thiru, S.: Cyclosporin A: Preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Trans. Proc.11, 1, 860–864 (1979)
Green, C.L., Allison, A.C.: Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin A treatment. LancetI (8075), 1182–1183 (1978)
Hess, A. D., Matyas, J. R., Tutschka, P. J.: Inhibition of in vitro human lymphocyte responses by cyclosporin A. Exp. Hematol. (submitted) (1979)
Hess, A. D., Tutschka, P. J.: Cyclosporin A induces specific suppressor cells in vitro (in preparation).
Kostakis, A.J., White, D.J.G., Calne, R.Y.: Prolongation of rat heart allograft survival by cyclosporin A. IRCS Med. Sci.5, 595 (1977)
Leoni, P., Garcia, R.C., Allison, A.C.: Effects of cyclosporin A on human lymphocytes in culture. J. Clin. Lab. Immunol.1, 67–72 (1978)
Monaco, A.P., Wood, M.L., van der Werf, B.A., Russell, P.S.: Effects of antilymphocyte serum in mice, dogs, and man. In: Antilymphocyte serum. Ciba Foundation Study Group No. 29. Wolstenholme, G.E.W., O'Connor, M. (eds.). London: J. A. Churchill, LTD. 1967
Naik, R.B., Abdeen, H., English, J., Chakraborty, J., Slapak, M., Lee, H.A.: Prednisolone withdrawal after 2 years in renal transplant patients receiving only this form of immunosuppression. Trans. Proc.11, 1, 39–44 (1979)
Najarian, J.S., Archer, N.L.: Causes and management of rejection. Trans. Proc.11, 1, 11–16 (1979)
Petcher, T.J., Weber, H.P., Ruegger, A.: Crystal and molecular structure of an Iodo-derivative of the cyclic undecapeptide cyclosporin A. Helv. Chim. Acta59 (5), 1480–1489 (1976)
Powles, R.L., Barrett, A.J., Clink, H., Kay, H.E.M., Sloane, J., McElwain, T.J.: Cyclosporin A for the treatment of graft-versus-host disease in man. LancetII, 1327–1331 (1978)
Ruegger, A., Kuhn, M., Lichti, H., Loosli, H.-R., Huguenin, R., Quiquerez, C., von Wartburg, A.: Cyclosporin A, ein immunsuppressiv wirksamer Peptidmetabolit aus Trichoderma polysporium (Link ex Pers) Rafai. Helv. Chim. Acta59 (4), 1075–1092 (1976)
Santos, G.W., Elfenbein, G.J., Tutschka, P.J.: Bone marrow transplantation — present status. Trans. Proc.,11, 1, 182–188 (1979)
Santos, G.W.: Bone marrow transplantation. In: Advances in Internal Medicine. Vol. 24, pp. 157–182. Chicago: Year Book Medical Publishers 1979
Slavin, S., Zan-Bar, J., Strober, S.: Generation of protein-specific and alloantigen-specific suppressor cells following tota! lymphoid irradiation in mice. Trans. Proc.11, 1, 891–894 (1979)
Tutschka, P.J., Santos, G.W.: Marrow transplantation in the Busulfan treated rat. I. Effect of cyclophosphamide and rabbit-anti-rat thymocyte serum as immunosuppression. Transplantation20, 101–106 (1975)
Tutschka, P. J., Beschorner, W.E., Allison, A.C., Burns, W.H., Santos, G.W.: Use of cyclosporin A in allogeneic bone marrow transplantation (BMT) in the rat. Nature (in press) (1979)
Tutschka, P. J., Beschorner, W.E., Hess, A.D.: Use of cyclosporin A (CsA) to prevent graftversus-host disease (GVHD) in a rat model of allogeneic marrow transplantation. Blut (in press) (1979)
Tutschka, P.J., Santos, G.W., Beschorner, W.E.: Role of suppressor cells in transplantation tolerance. Trans. Proc.11, 1, 882–886 (1979)
Tutschka, P.J., Schwerdtfeger, R., Slavin, R., Santos, G.W.: Mechanism of donor to host tolerance in rat bone marrow chimeras. In: Experimental hematology today. Baum, S.J., Ledney, G.D. (eds.), pp. 191–197. Berlin, Heidelberg, New York: Springer 1977
White, D.J.G., Plumb, A.M., Pawelec, G., Brons, G.: Cyclosporin A: An immunosuppressive agent preferentially against proliferative T cells. Transplantation27 (1), 55–58 (1979)
White, D.J.G., Calne, R.Y., Plumb, A.: Mode of action of cyclosporin A: A new immunosuppressive agent. Trans. Proc.11, 1, 855–859 (1979)
Williams, C.M.: Progress in clinical renal transplantation. Trans. Proc.11, 1, 4–10 (1979)
Author information
Authors and Affiliations
Additional information
Supported by ACS Grant No. CH-113, ACS Institutional Research Grant No. IN-11P.
Rights and permissions
About this article
Cite this article
Tutschka, P.J. Cyclosporin A — A new outlook for immunosuppression in clinical transplantation. Blut 39, 81–87 (1979). https://doi.org/10.1007/BF01008083
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01008083